Fw. Kreth et al., SUPRATENTORIAL WORLD-HEALTH-ORGANIZATION GRADE-2 ASTROCYTOMAS AND OLIGOASTROCYTOMAS - A NEW PATTERN OF PROGNOSTIC FACTORS, Cancer, 79(2), 1997, pp. 370-379
BACKGROUND. Prognostic factors for adult patients with supratentorial
World Health Organization (WHO) Grade 2 astrocytomas are poorly define
d. METHODS. The prognostic importance of pretreatment patient- and tum
or-related factors was analyzed retrospectively in 197 adult patients
with supratentorial astrocytomas (n = 153) or oligoastrocytomas (n = 4
4) using the multivariate Cox proportional hazards model. Endpoints we
re death and date of malignant transformation. All patients were treat
ed similarly between 1979 and 1992 with iodine-125 implants as the pri
mary treatment. RESULTS. A new prognostic pattern was detected. Unfavo
rable prognostic factors with regard to survival were 1) a tumor volum
e greater than or equal to 20 mt; 2) a performance status less than or
equal to 80; and 3) age greater than or equal to 40 years for the fem
ale subpopulation. Midline shift (another important tumor-related fact
or after univariate analysis) was highly correlated with tumor volume
and therefore not included in the multivariate model. Risk factors of
malignant transformation were 1) a tumor volume greater than or equal
to 20 mt; 2) an enhancement in the computed tomography scan; and 3) ag
e greater than or equal to 40 years for the female subpopulation. Prog
nostic factors created subsets of patients with 5-year survival rates
ranging from as low as 5% to as high as 79%. CONCLUSIONS. Any treatmen
t decision or evaluation of treatment efficacy should take into accoun
t the strong influence of both patient- and tumor-related factors. Any
further study design should consider the detected interaction between
gender and age and the importance of tumor volume. (C) 1997 American
Cancer Society.